NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
39 hedge funds and large institutions have $1.13M invested in NeuBase Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 11 closing their positions.
Holders
39
Holders Change
-4
Holders Change %
-9.3%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
10
Closed
11
Calls
$11K
Puts
$33K
Net Calls
-$22K
Net Calls Change
-$16K